Reply to "Comment on: 'Children with chronic urticaria can be effectively controlled with updosing second-generation antihistamines'"
J Am Acad Dermatol
.
2020 Nov;83(5):e365-e366.
doi: 10.1016/j.jaad.2020.06.997.
Epub 2020 Jul 1.
Authors
Sofianne Gabrielli
1
,
Michelle Le
2
,
Elena Netchiporouk
3
,
Barbara Miedzybrodzki
3
,
Sharon Baum
4
,
Shoshana Greenberger
4
,
Petra Staubach-Renz
5
,
Moshe Ben-Shoshan
6
Affiliations
1
Division of Allergy, Immunology and Dermatology, Montreal Children's Hospital, Montreal, Quebec, Canada. Electronic address: sofiannegabrielli@gmail.com.
2
Division of Allergy, Immunology, and Dermatology, McGill University, Montreal, Quebec, Canada.
3
Division of Dermatology, McGill University, Montreal, Quebec, Canada.
4
Department of Dermatology, Sheba Medical Center, Ramat-Gan, Tel-Aviv University, Tel-Aviv, Israel.
5
Department of Dermatology and Allergy, University Medical Center, Mainz, Germany.
6
Division of Allergy, Immunology and Dermatology, Montreal Children's Hospital, Montreal, Quebec, Canada.
PMID:
32622144
DOI:
10.1016/j.jaad.2020.06.997
No abstract available
Publication types
Letter
Comment
MeSH terms
Child
Chronic Disease
Chronic Urticaria*
Histamine H1 Antagonists, Non-Sedating*
Humans
Urticaria* / drug therapy
Substances
Histamine H1 Antagonists, Non-Sedating